127 related articles for article (PubMed ID: 15838515)
1. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues.
Pei XH; Xiong Y
Oncogene; 2005 Apr; 24(17):2787-95. PubMed ID: 15838515
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors.
Malumbres M; Ortega S; Barbacid M
Biol Chem; 2000; 381(9-10):827-38. PubMed ID: 11076015
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase inhibitors.
Fischer PM; Endicott J; Meijer L
Prog Cell Cycle Res; 2003; 5():235-48. PubMed ID: 14593718
[TBL] [Abstract][Full Text] [Related]
4. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression.
Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M
Oncogene; 2007 Dec; 26(55):7665-74. PubMed ID: 17599058
[TBL] [Abstract][Full Text] [Related]
5. Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.
Nonomura Y; Nagasaka K; Hagiyama H; Sekine C; Nanki T; Tamamori-Adachi M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2006 Jul; 54(7):2074-83. PubMed ID: 16802342
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
[TBL] [Abstract][Full Text] [Related]
7. Functions, regulation and cellular localization of plant cyclin-dependent kinase inhibitors.
Wang H; Zhou Y; Bird DA; Fowke LC
J Microsc; 2008 Aug; 231(2):234-46. PubMed ID: 18778421
[TBL] [Abstract][Full Text] [Related]
8. The INK4 family of cell cycle inhibitors in cancer.
Roussel MF
Oncogene; 1999 Sep; 18(38):5311-7. PubMed ID: 10498883
[No Abstract] [Full Text] [Related]
9. Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.
Byth KF; Cooper N; Culshaw JD; Heaton DW; Oakes SE; Minshull CA; Norman RA; Pauptit RA; Tucker JA; Breed J; Pannifer A; Rowsell S; Stanway JJ; Valentine AL; Thomas AP
Bioorg Med Chem Lett; 2004 May; 14(9):2249-52. PubMed ID: 15081018
[TBL] [Abstract][Full Text] [Related]
10. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid induces CDK inhibitors and growth arrest specific (Gas) genes in neural crest cells.
Wang L; Mear JP; Kuan CY; Colbert MC
Dev Growth Differ; 2005 Apr; 47(3):119-30. PubMed ID: 15839997
[TBL] [Abstract][Full Text] [Related]
12. Anti-migratory and anti-angiogenic effect of p16: a novel localization at membrane ruffles and lamellipodia in endothelial cells.
Alhaja E; Adan J; Pagan R; Mitjans F; Cascalló M; Rodríguez M; Noé V; Ciudad CJ; Mazo A; Vilaró S; Piulats J
Angiogenesis; 2004; 7(4):323-33. PubMed ID: 15886876
[TBL] [Abstract][Full Text] [Related]
13. Imidazo[1,2-a]pyridines. Part 2: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors.
Byth KF; Culshaw JD; Green S; Oakes SE; Thomas AP
Bioorg Med Chem Lett; 2004 May; 14(9):2245-8. PubMed ID: 15081017
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?
Besson A; Assoian RK; Roberts JM
Nat Rev Cancer; 2004 Dec; 4(12):948-55. PubMed ID: 15573116
[TBL] [Abstract][Full Text] [Related]
15. Progress in the evaluation of CDK inhibitors as anti-tumor agents.
McInnes C
Drug Discov Today; 2008 Oct; 13(19-20):875-81. PubMed ID: 18639646
[TBL] [Abstract][Full Text] [Related]
16. The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light.
Al-Mohanna MA; Al-Khalaf HH; Al-Yousef N; Aboussekhra A
Nucleic Acids Res; 2007; 35(1):223-33. PubMed ID: 17158160
[TBL] [Abstract][Full Text] [Related]
17. Effects of a CDK inhibitor on lens regeneration.
Tsonis PA; Madhavan M; Call MK; Gainer S; Rice A; Del Rio-Tsonis K
Wound Repair Regen; 2004; 12(1):24-9. PubMed ID: 14974961
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time.
Chkhotua AB; Abendroth D; Froeba G; Schelzig H
Transpl Int; 2006 Jan; 19(1):72-7. PubMed ID: 16359379
[TBL] [Abstract][Full Text] [Related]
19. CDK inhibitors in cancer therapy: what is next?
Malumbres M; Pevarello P; Barbacid M; Bischoff JR
Trends Pharmacol Sci; 2008 Jan; 29(1):16-21. PubMed ID: 18054800
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle molecules in mesothelioma: an overview.
Spugnini EP; Campioni M; D'Avino A; Caruso G; Citro G; Baldi A
J Exp Clin Cancer Res; 2007 Dec; 26(4):443-9. PubMed ID: 18365537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
